Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2016

View Archived Issues

Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection

New phase Ib study investigates dantrolene sodium for Wolfram syndrome

Primex Pharmaceuticals submits MAA for ADV-6209

Synthetic Biologics awarded CDC contract for SYN-004

RedHill Biopharma provides update on phase III study of RHB-104

Asceneuron receives grant from MJFF

ICU Medical to acquire Pfizer's Hospira Infusion Systems business

Vaccinex, Merck KGaA form collaboration to evaluate VX15/2503 plus avelumab in NSCLC

Santen, RIKEN and FBRI to develop novel retinal disease treatments

Engility awarded task order by Walter Reed for Chikungunya virus vaccine work

FDA accepts Coherus' BLA submission for pegfilgrastim biosimilar

ZF-AAV constructs enables long-term mutant Huntingtin repression in mice

Promising phase II data presented for E-52862

First patient enrolled in Reata Pharmaceuticals' phase III study of bardoxolone methyl

Boston Therapeutics and Advance Pharmaceutical report topline data from study of BTI-320

University of Ljubljana patents PSMB8 inhibitors

NIH grant supports work at IDRI to develop RNA-based Zika virus vaccine

Akarna Therapeutics discloses FXR agonists

Shanghai Yingli Pharmaceutical describes URAT1 inhibitors

Mironid develops PDE4 activators

Hokkaido University presents oxidative stress-induced cell death inhibitors

AstraZeneca to divest ex-U.S. Rhinocort Aqua rights to Cilag

MonoSol Rx and Lupin to develop pediatric products utilizing PharmFilm technology

EMA grants orphan drug designation to Videregen's replacement trachea product

TRPM8 antagonist attenuates oxaliplatin-induced cold allodynia in vivo

GSK makes success payment to Cancer Research Technology and University of Manchester

Teva to commercialize two Celltrion biosimilar candidates in U.S. and Canada

NIH awards support research on the peripheral nervous system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...